Maverick Capital

Superinvestor

Maverick Capital Ltd

SEC CIK: 0000934639
Manager: Lee Ainslie
Style: Hedge fund
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Maverick Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overview All 13F holders of CPRX Full Q2 2026 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q2 2021

Holdings of CPRX by Maverick Capital, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−35,869−100.0%	Sold out	Holders
Q2 2021	35,869	$206.0K	<0.1%	+35,869	New	Holders